METRONOMIC ORAL GEMCITABINE FOR CANCER THERAPY

• 收藏
• 分享

专利权人:

INNOPHARMAX; INC.

发明人:

HAO, WEI-HUA,HSUEH, SHU-PIING,HSU, CHANG-SHAN

申请号：

CA3026144

公开号：

CA3026144A1

申请日:

2017.06.02

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

Use of gemcitabine, including in self-emulsifying orally administered dosage forms for treatment, such as inducing regression or inhibiting growth, of tumors in a patient such as a human. Gemcitabine is orally administered in a metronomic manner.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/